Mr. Xia Zuoquan, graduating from University of Science and Technology Beijing and Peking University’s Guanghua School of Management, is the angel investor of Annoroad and the co-founder of BYD and acts as the Chairman of Annoroad, the Chairman of Shenzhen Zhengxuan Investment and the Director of BYD now. He, as one of the successful entrepreneurs and investors at home, boasts the rich experience in the multiple fields such as the enterprise governance and the risk control.

Mr. Li Zhimin, Senior engineer, MBA from University of Washington, USA, Master of Medicine from Xi’an Medical University; council member of China Healthy Birth Science Association, executive committee member of Beijing Federation of Commerce and Industry, and public supervisor for optimizing business environment in Beijing; titles and honors include: 1st prize of Hubei Science and Technology Achievement Promotion Award in 2021, and “Outstanding Individual of Winter Olympics/Winter Paralympics in Beijing”; 10 SCI papers published and 10 patents granted; former expert member of the National Pharmaceutical Price evalsuation Expert Committee, chair and speaker of medical forums in consecutive years; more than 30 years of management experience in medical and health industry; former general manager or CEO of several renowned listed pharmaceutical companies in China (Conba Pharmaceutical, Buchang Pharmaceuticals, Fosun & Wanbang Pharmaceutical, etc.

Mr. Wang Hailiang, graduating from Shandong University (the former Shandong Medical College) where he majored in Pharmaceutics and Peking University’s Guanghua School of Management which awarded an MBA to him, boasts over 20 years of experience in the marketing management in the pharmaceutical industry. He once engaged in the pharmaceutical marketing at Beijing Hospital and MSD (China) and acted as the Vice President of Juneng Pharmaceutical, a former listed company in Hong Kong.